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Background:  Authors  have reported  better  outcomes,  by  reducing  surgical  dissection  for  carpal  tunnel
syndromes  requiring  surgery.  Recently,  a new  sonographically  guided  technique  for  ultra  minimally
invasive  (Ultra-MIS)  carpal  tunnel  release  (CTR)  through  1 mm  incision  has been  described.
Hypothesis: We  hypothesized  that  a clinical  trial for comparing  Ultra-MIS  versus  Mini-open  Carpal  Tunnel
Release  (Mini-OCTR)  was feasible.
Materials  and  methods:  To  test  our  hypothesis,  we  conducted  a pilot  study  for  studying  Ultra-MIS  versus
Mini-OCTR  respectively  performed  through  a  1  mm  or a 2 cm  incision.  We  deﬁned  success  if primary
feasibility  objectives  (safety  and efﬁcacy)  as  well  as  secondary  feasibility  objectives  (recruitment  rates,
compliance,  completion,  treatment  blinding,  personnel  resources  and sample  size calculation  for  the
clinical trial)  could  be  matched.  Score  for Quick-DASH  questionnaire  at  ﬁnal  follow-up  was  studied  as  the
primary variable  for the  clinical  trial.  Turnover  times  were  studied  for  assessing  learning  curve  stability.
Results:  Forty  patients  were  allotted.  Primary  and  secondary  feasibility  objectives  were  matched  with
the following  occurrences:  70.2%  of eligible  patients  ﬁnally  recruited;  4.2%  of randomization  refusals;
26.6  patients/month  recruited;  100%  patients  receiving  a blinded  treatment;  97.5%  compliance  and  100%
completion.  A sample  size  of 91  patients  was  calculated  for clinical  trial validation.  At  ﬁnal  follow-up,
preliminary  results  for Quick-Dash  substantially  favored  Ultra-MIS  over  Mini-OCTR  (average  14.54  versus
7.39) and complication  rates  were  lower  for Ultra-MIS  (5%  versus  20%).  A  stable  learning  curve  was
observed  for  both  groups.
Conclusions:  The  clinical  trial  is feasible.  There  is currently  no  evidence  to contraindicate  nor  withhold
the  use  of  Ultra-MIS  for  CTR.
Level  of evidence:  III.
© 2014  Elsevier  Masson  SAS.  All  rights  reserved.. Introduction
With an incidence of 1 to 3 and a prevalence of 50 cases per 1000
erson-years, carpal tunnel syndrome (CTS) is the most diagnosed
ntrapment neuropathy [1,2]. Surgery can be considered as a ﬁrst
ffective option in CTS if there is clinical evidence of median nerve
enervation [1,3–5]. The incision’s size for carpal tunnel release
CTR) has been described as classic (> 4 cm)  [6,7], limited (2–4 cm)
6,7], mini (1.0–2 cm)  [4,7,8], percutaneous (0.4–0.6 cm)  [4,9,10]
Abbreviations: CTR, carpal tunnel release; CTS, carpal tunnel syndrome; Mini-
CTR, mini-open CTR; OCTR, classic open CTR; SEM, standard error of the mean;
CL,  transverse carpal ligament; Ultra-MIS, ultra minimally invasive surgery.
∗ Corresponding author.
E-mail address: k2rojo@yahoo.com (J.M. Rojo-Manaute).
http://dx.doi.org/10.1016/j.otsr.2013.11.015
877-0568/© 2014 Elsevier Masson SAS. All rights reserved.and ultra minimally invasive (≤ 1 mm)  [11]. When comparing CTR
techniques with different incision lengths, the smaller incisions
show a faster return to work and better cosmetic results [6,12] and
lower pain rates [4,8,13–16]. Endoscopic CTR has shown clinical
superiority to classic open CTR (OCTR) [1,3,4,8,17], however, con-
cerns persist over incomplete releases in cadavers [1,6,8,17,18] and
complications to neurovascular structures and tendons [1,4,8,17].
Mini-OCTR has matched endoscopic CTR in clinical results and
morbidity [1,4,5,19,20], however there is concern that part of the
procedure is performed blindly (Blind mini-OCTR) [1,4,5,21].
Recent anatomic ﬁndings [22] suggest that a complete nerve
release is possible by sectioning the deepest ﬁbrous layer without
intruding into the more superﬁcial palmar anatomy, which is rich in
nerve ﬁbers that may  elicit local pain when surgically injured [4,23].
Mini and percutaneous approaches have been described using
ultrasounds [4,8–11]. In their ﬁrst work, Nakamichi et al. [8]
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Fig. 1. Surgical details for Ultra-MIS CTR. A. Distal volar forearm approach (ﬁrst
available antebrachial skin crease 2 cm or greater proximal to the pisiform). B. Skin
incision right after and 48 hours postsurgical release (enlarged image).
Table 1
Secondary feasibility objectives.
Variable Deﬁnition of success Results
Recruitment
rates
[24,27–29]
≥ 70% of eligible
patients recruited [30]
40 (70.2%) of 57 eligible
patients recruited
≤ 5% of eligible patients
refused randomization
[31]
2 (4.2%) refused
randomization
≥ 10 patients
randomized at our
centre per month, on
average
26.6 patients/month
randomized
Blinding [29,32] > 90% of the
randomized patients
received treatment in a
blinded manner
100% received blinded
treatment
Compliance [28] > 90% of our patients
attended all follow-up
dates
Compliance was 97.5%
Completion [27] More than 90% came to
our last follow-up
Completion was a 100%
Personnel resources [27] The process time for
concealment (surgical
wound taping) and
data-gathering in our
protocol could not
overload our personnel
resources
Concealment overloaded
our resources and was
modiﬁed: patients
avoided revealing their
palms to data collectors.
Suspected complications
were assessed by an
independent experienced
hand surgeon without88 A. Capa-Grasa et al. / Orthopaedics & Traum
ompared a distal anterograde ultrasound assisted Mini-OCTR
gainst OCTR and, in their later study [4], they compared an
ltrasound-guided percutaneous CTR to an ultrasound assisted
ini-OCTR. Both works [4,8] reported signiﬁcant clinical differ-
nces regarding grip, pain and scar tenderness (until the 6th week)
nd less scar sensitivity (until the 13th week) that favored the
echnique with the smallest approach. Other authors [9,10] have
escribed in cadavers a proximal retrograde ultrasound-guided CTR
sing an arthroscopic trocar, reporting safe and successful results.
Rojo et al. [11] have shown that an ultrasound-guided Ultra-MIS
TR can be achieved safely and effectively in cadavers and that the
elease can be speciﬁcally restricted to the deepest ﬁbrous layer of
he carpal tunnel (TCL and deep investing fascia of the forearm),
reserving the anatomy superﬁcial to TCL [11]. The Ultra-MIS skin
ncision is 4 to 12 times smaller than the percutaneous approaches
4,8–10] and it is, to our knowledge, the smallest described surgical
pproach for CTR. However, Ultra-MIS CTR has not been performed
linically.
The purpose of this study was to evaluate feasibility for a ran-
omized, single-centre, clinical trial comparing Ultra-MIS with
ini-OCTR for CTR in patients with CTS.
. Materials and methods
This was a one-centre individual randomized, parallel group,
ontrolled, superiority external pilot study [24] conducted in
adrid, Spain, in an ambulatory ofﬁce-based setting at our third
evel referral hospital. Patients were consecutively recruited and
perated between October and December, 2009 and followed up
or 3 months. Eligible participants had clinical signs [25] of pri-
ary CTS and a positive electrodiagnostic test. Exclusion criteria
ere hand/wrist pathology or malformations, secondary CTS, treat-
ent trial with local corticosteroid injection, age under 18, or any
revious injury on any hand. Previous criteria for ambulatory surgi-
al care exclusion were also applied [26]. Outcome assessors were
linded by taping the patient’s wrists. Patients followed concealed
llocation (1:1), by an independent blocked computer generated
ist, to one of two surgical treatments: Ultra-MIS or Mini-OCTR.
Ultra-MIS consisted of an ultrasound-guided percutaneous ret-
ograde release of the deepest ﬁbrous layer of the carpal tunnel
hrough a ≤ 1 mm proximal incision (Fig. 1), located at the distal
orearm, as described by Rojo-Manaute et al. [11] and shown in
ig. 2. Mini-OCTR was performed as described by Zyluk et al. [21],
sing mini-retractors and surgical scissors through a 2 cm curved
kin incision 6 mm ulnar and parallel to the thenar crease, in line
ith the long axis of 4th ﬁnger and ending just distal to the trans-
erse wrist crease (Fig. 3). In the Mini-OCTR group, the superﬁcial
nd intermediate ﬁbrous layers [11,22] were divided and the TCL
as released as far distally as the fat around the superﬁcial vascular
rch; proximally, the antebrachial intermediate and deep ﬁbrous
ayers [11,22] were divided as far as 1 cm proximal to the pisiform.
Success was determined if all feasibility objectives for the pilot
tudy were matched: (1) primary objectives, safety (deﬁned as no
eurovascular morbidity) and efﬁcacy (no CTS relapse), 3 months
fter surgery; (2) secondary objectives, as deﬁned in Table 1; and
3) sample size calculation for the clinical trial, based on the data
or the primary outcome measure of the main study (Quick-DASH)
t ﬁnal follow-up.
Variables for the clinical trial were also studied in this pilot
tudy, looking for evidence for contraindicating or withholding
he use of Ultra-MIS, (1) preoperatively: symptoms duration,
uick-DASH, employment status (labour/retired) and previous
onservative treatments; (2) intraoperatively: turnover time per
rocedure, deﬁned as the minutes between two consecutive
atients entering the same operating room [26]. Turnover times
revealing the study group
Values show mean ± SEM. *P < 0.05.
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Fig. 2. Description of the Ultra-MIS CTR. A (axial plane): piercing of the AF to the
underlying ﬂexor tendon space (Abbocath 16G). B (axial plane): intracanal advance
of  Acufex 3.0-mm diameter hook knife (010600; Smith & Nephew PLC, London,
England) through the previous Abbocath’s tunnel. C (sagittal plane): positioning
of  the hook knife in the distal cutting point (2–3 mm proximal to the SPA) and ret-
rograde release of the deepest ﬁbrous layer (back pulling of the hook knife while
applying volar pressure) to the exit through the point of entry. AF: antebrachial
fascia; a: ulnar artery; v: ulnar vein; m:  median nerve; T: ﬂexor tendon space; Th:
thenar eminence; TCL: transverse carpal ligament; SPA: superﬁcial palmar arch;
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Ihite arrow: tip of the surgical instrument; white triangles: body of the surgical
nstrument; dotted arrow line: surgical release path.
ere used for studying our learning curve following the meth-
ds described by Rojo-Manaute et al. [26]. A learning curve was
eﬁned as “stable” (no more signiﬁcant learning) if the linear coef-
cient of determination (R2) for turnover time was less than 0.26
26]. A data committee (ACG, FCR, MVM  and JVM) reviewed R2
or the last 10 procedures in each surgical group; (3) 1, 3 and
 weeks and 3 months postoperatively: Quick-DASH (administered
y the examiner), Grip Strength Rate (JAMAR, Hydraulic Hand
ynamometer. Bolingbrook, IL, USA) and two points discrimination
ere recorded, and patients were asked to recall [33] the recovery
ime (days) until they stopped using pain killers, had full wrist range
f motion and performed their daily activities (including work); and
4) complications.
All Ultra-MIS were performed by the second author using a
ortable, real-time, linear array ultrasound scanner (LOGIQ Book XP
ro, 5–11 MHz  8L, GE Healthcare, Madrid, Spain). Mean, standard
rror of the mean (SEM) and range were recorded (SPSS 15.0,
nc, Chicago, IL). t-test and Chi2 (signiﬁcant at P < 0.05) wereFig. 3. Surgical details for Mini-OCTR. A. Location and incision size. B. Surgical
approach.
treated as preliminary (no power calculations performed). Institu-
tional review board approval and written informed consent were
obtained for this study.
3. Results
Forty of 57 eligible patients were randomly allocated to Ultra-
MIS  or Mini-OCTR group (Fig. 4) showing respectively no signiﬁcant
differences in: average age, 62.5 (range, 31–83) versus 58.4 (range,
30–83) years; presurgical symptom duration, 37.4 (range, 4–118)
versus 37.9 (range, 2–137) months; labor status, 12 versus 11
employed; nor sex, 2 versus 3 males. Primary objectives were
matched in both groups. Results for secondary feasibility objectives
are shown in Table 1.
Results for our pilot study for Quick-DASH and Grip Strength
Rate are shown in Fig. 5. Comparing Ultra-MIS versus Mini-OCTR,
patients required an average (±SEM) of: (1) 2.1 ± 0.72 versus
14.23 ± 3.18 days for stopping oral analgesics; (2) 1.65 ± 0.76 versus
7.8 ± 2.69 days for complete wrist extension; (3) 2.5 ± 0.75 ver-
sus 11.75 ± 3.82 days for complete wrist ﬂexion; (4) 1.86 ± 1.59
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Fig. 4. Patient ﬂow diagram showing participant progress.
Fig. 5. Quick-DASH (A) and Grip Strength Rate (B) after Ultra-MIS (red) or Mini-OCTR (black) measured preoperatively (Presurg) and postoperatively (3, 6 and 12 weeks).
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Puick-DASH measured in 0–100 scale. Grip Strength Rate for the operated hand w
ominant uninjured side − 10% = calculated normal strength of the injured non-dom
f  the injured dominant side [34]. Values show mean ± 2 SEM. Mini-OCTR vs Ultra-
ersus 12.6 ± 9.04 days for relieving paresthesia; and (5) 4.35 ± 1.45
ersus 25.85 ± 5.37 days for returning to their normal daily liv-
ng (including work activities). Differences between groups were
tatistically signiﬁcant except for the days taken for relieving pares-
hesia (P > 0.05). No complications were registered in either group.
For the last 10 cases in each group, the average (±SEM) turnover
ime was signiﬁcantly lower for Ultra-MIS (19.1 ± 1.41 minutes)
han for Mini-OCTR (25.8 ± 1.73 minutes), however, learning curves
ere stable for both groups (R2 = 0.15 and R2 = 0.05, respectively,
 < 0.05).pressed as a percentage of the individual’s normal grip calculated as: strength of
side; or strength of non-dominant uninjured side + 10% = calculated normal strength
P < 0.05; **P > 0.05.
We  calculated a sample size of 82 patients (power: 80%; conﬁ-
dence level: 95%) using Epidat 3.1, based on the mean ± standard
deviation values for Quick-DASH in the Mini-OCTR (14.54 ± 13.95)
and Ultra-MIS (7.38 ± 8.23) groups. To ensure sample size, we  will
include 10% more patients in the ﬁnal study (91 in total).4. Discussion
The rationale for developing alternative CTR options is to
reduce morbidity from surgical collateral damage to non-etiologic
atolog
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tructures [1,4,5,7,8]. Although sonographic percutaneous
pproaches [4,9,10] use the smallest surgical approach to date,
here are questions about their generalizability: e.g., large list
f contraindications [4,8], release extent at the deepest layer
ortions [4,9,10], best approach location [4,23,30], best advancing
irection of the instrument [34,35] and size of the instrument’s
coustic shadows. On the basis of the perceived limitations of the
rior techniques [4,8–10], Rojo-Manaute et al. [11] have recently
eveloped a safe and effective sonographically guided Ultra-MIS
TR in cadavers. The main technical advantages of Ultra-MIS are:
1) the Acufex blade’s 2-mm width allows for a 1-mm incision,
ts 1-mm thickness produces a small sonographic shadow and its
-mm diameter matches the transverse carpal ligament thickness
11,22,31]; (2) the distal volar forearm approach allows targeting
solately the deepest ﬁbrous layer of the carpal tunnel [11,22] while
voiding injuring the denser innervation at the palm, all of which
ay  reduce morbidity and postoperative pain [5,7,9,15,22,23,36].
ince Ultra-MIS CTR has not been performed clinically, the present
tudy should help to design a clinical trial proving its feasibility.
The ﬁrst goal of our pilot study was to evaluate our speciﬁc feasi-
ility objectives for a future clinical trial. Our results showed that:
1) CTR was safe (no neurovascular complications) and effective
no relapses) in both groups; (2) we matched our objectives for
ecruitment (criteria of eligibility were sufﬁcient), blinding, com-
liance and completion rates (Table 1); and (3) the protocol would
eed modiﬁcations to the concealment of the surgical wound to
ata collectors. Taping the wrists created an overload in our per-
onnel resources so we instructed patients to avoid revealing their
ound to the data collector, however, this created a potentially
uboptimal concealment that is a limitation to this study (Table 1).
n the subsequent clinical trial, patients will be given a dressing to
over their skin wound before entering the data collector’s ofﬁce
n each postsurgical visit. Although, to our knowledge, there is no
uideline in literature for setting a proper threshold for recruitment
ate among eligible patients, Choi et al. [37] set a similar threshold
70%) and their study was later cited by Thebane [27] as an exam-
le of a setting up good thresholds. Regarding the sample size for
ur pilot study (n = 40), several authors [24,27,28] have discussed
hat a sample size calculation is not necessary for pilot studies, sug-
esting that sample size should depend on the parameter(s) to be
stimated and that a general rule of thumb is to take 30 patients
r greater [24,38]. However, there is not much consensus since in
he analysis performed by Arnold et al. [29] the median number
f patients in the studies that they included was  52 (average 59.6,
ange 20–120). Therefore, our sample size was above the recom-
endations given by Lancaster and inside the range recommended
y Arnold.
The second goal of this study was to study our patient’s response
o the intervention. Our early results showed that Ultra-MIS had a
arger recovery of physical function and symptoms in less post-
perative time than Mini-OCTR, nevertheless, Grip Strength Rate
id not show signiﬁcant differences between groups throughout
he study (Fig. 5); however these results should be interpreted
ith caution since pilot studies are not designed for hypothesis
esting and its results are not supported by a sample size with
dequate power [24,27,29]. Our subsequent trial would allow us
o properly compare the clinical outcomes of the two techniques.
ltra-MIS used less turnover time per procedure than mini-OCTR
nd our learning curves were “stable” in our last 10 procedures in
oth groups. In this work, we required to assess “stability” because
he total economic costs of a procedure are directly dependant on
urnover times and these, in turn, are dependent on learning curves
26]. Learning curves plot performance with respect to ability over
ime, thus, if a clinician is learning, the curve will follow a so-called
power law of practise”. Data for learning curves is obtained from
he “power law” slope and ﬁt to a model. The slope indicates the
[
[y: Surgery & Research 100 (2014) 287–292 291
speed at which learning occurs (not needed for this study) and
the curve ﬁt can be measured using a statistical model under the
generalized linear model. We  used a linear regression model to ﬁt
our numerical continuous variables and interpreted R2 as “stable”
(weak learning inﬂuence) for R2 < 0.26; and a ﬁnal sample size of
91 patients was determined [26]. For sample size calculations, our
follow-up period was  limited to three months based on Nakamichi’s
[4,8] previous results since, for most of their clinical data, they only
reported signiﬁcant differences up to the sixth week. The Quick-
DASH was established as our primary variable due to its known
validity, reliability and responsiveness for monitoring upper limb
physical function and symptoms in several languages (including
Spanish).
In conclusion, a prospective, randomized clinical trial, compar-
ing Mini-OCTR versus Ultra-MIS, is feasible in terms of potential
safety and efﬁcacy, processing and resource objectives and sam-
ple size calculations. While a randomized trial is still needed for
generalizing its clinical use, to our knowledge, there is currently
no evidence to neither contraindicate nor withhold the use of
Ultra-MIS in patients with symptomatic CTS and a positive elec-
trodiagnostic tests.
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